Vial

INDIVIDUAL TEST 838

Glycine Receptor Antibodies (IgG)

Indication

Suspicion of Stiff person syndrome and especially PERM (Progressive encephalomyelitis with rigidity and myoclonus).

Sample material

Serum

  • Minim. volume: 0,5 mL

CSF

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: room temperature
  • International: cold

Method

Cell-based assay (CBA), indirect immunofluorescence (IIF)

Reference interval

Serum: <1:10 negative

CSF: negative

Result

Results are reported as negative or positive. A positive result is followed by a titer (serum).

Interpretation

GlyR mediates the post-synaptic inhibition in the central nervous system. GlyR antibodies are primarily associated with PERM (progressive encephalomyelitis with rigidity and myoclonus) variant of stiff person syndrome. In less than 10% of cases, anti-GlyR antibodies are associated with underlying malignancy.

References

  • Alexopoulos H, Dalakas MC. J Autoimmun. 2019. The immunobiology of autoimmune encephalitides. PMID: 31611142
  • Graus F, et al. Neurol Neuroimmunol Neuroinflamm. 2021. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. PMID: 34006622
  • Guasp M et al. Neurol Neuroimmunol Neuroinflamm. 2025. Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies: Clinical Features and Outcomes. PMID: 40953327
  • Winklehner M et al. Neurol Neuroimmunol Neuroinflamm. 2024. Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies: Case Report and Potential Mechanisms. PMID: 39213470
  • Cullinane PW et al. Handb Clin Neurol. 2024. Stiff person syndrome. PMID: 39174250
  • Chia NH et al. Ann Clin Transl Neurol. 2023. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. PMID: 37212351

Last updated: 2025-11-25

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 838

Glycinreceptor-antikroppar (IgG)

Indikation

Misstanke om Stiff person syndrom och framför allt PERM (Progressiv encefalomyelit med rigiditet och myoklonier)

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Likvor

  • Minim. volym: 0,5 mL

Transport

  • Inom Sverige: rumstemperatur
  • Internationellt: kylt

Metod

Cell-based assay (CBA), indirekt immunofluorescens (IIF)

Referensintervall

Serum: <1:10 negativt

Likvor: negativt

Resultat

Resultat anges som negativt eller positivt. Positivt resultat titreras (serum).

Tolkning

GlyR medierar postsynaptisk inhibering i det centrala nervsystemet. GlyR antikroppar är associerade med varianten PERM (progressiv encefalomyelit med rigiditet och myoklonier) vid stiff person syndrome. I mindre än 10% av fallen är anti-GlyR antikroppar associerade med underliggande malignitet.

Referenser

  • Alexopoulos H, Dalakas MC. J Autoimmun. 2019. The immunobiology of autoimmune encephalitides. PMID: 31611142
  • Graus F, et al. Neurol Neuroimmunol Neuroinflamm. 2021. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. PMID: 34006622
  • Guasp M et al. Neurol Neuroimmunol Neuroinflamm. 2025. Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor Antibodies: Clinical Features and Outcomes. PMID: 40953327
  • Winklehner M et al. Neurol Neuroimmunol Neuroinflamm. 2024. Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies: Case Report and Potential Mechanisms. PMID: 39213470
  • Cullinane PW et al. Handb Clin Neurol. 2024. Stiff person syndrome. PMID: 39174250
  • Chia NH et al. Ann Clin Transl Neurol. 2023. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria. PMID: 37212351

Senast uppdaterat: 2025-11-25

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi

Hittar du inte vad du söker? Vi kan hjälpa till